The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

Global active pharmaceutical ingredients (API) market will reach $ 386.2 billion by 2032, growing by 6.4% annually over 2022-2032, driven by rising adoption of biologics in disease management, ...

North America active pharmaceutical ingredients (API) market is projected to grow by 4.8% annually in the forecast period and reach $120.7 billion by 2032, driven by rising adoption of biologics in ...

Catalent plans to invest an estimated $45 million to expand its facilities and purchase new equipment for its production ...

Globally, $105.3 billion worth of pharmaceuticals and biotech M&A deals have been inked so far in 2025, according to data ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...

Plc - Director Appointment, Board Change PR Newswire LONDON, United Kingdom, July 08 8 July 20254basebio PLC("4basebio" or the "Company")Director Appointment, Board ...

As part of Novo Holdings' takeover of pharmaceutical company Catalent last year, Novo Nordisk acquired a site in Italy along ...

Investing.com -- Italian authorities appointed a special commissioner on Monday to help Novo Nordisk (NYSE: NVO) deliver its planned €2 billion ($2.34 billion) investment in a factory near Rome.

Investing.com -- 意大利当局周一任命了一名特别专员，以帮助诺和诺德公司实现其计划在罗马附近投资20亿欧元（约合23.4亿美元）建设工厂的计划。 包括罗马在内的拉齐奥大区主席弗朗切斯科·罗卡被任命为阿纳尼工厂的特别专员。这一角色赋予他加速与该设施相关项目的权力，包括计划中的升级。

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...